Tadao Maeda

Title: Tadao Maeda: Innovator in Retinal Dysfunction Treatment

Introduction

Tadao Maeda is a notable inventor based in Mayfield Heights, OH (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment and prevention of age-related retinal dysfunction. With a total of 4 patents to his name, Maeda's work is paving the way for advancements in retinal health.

Latest Patents

One of Maeda's latest patents focuses on methods for the treatment and prevention of age-related retinal dysfunction. This innovative method involves administering a pharmaceutically effective amount of a synthetic retinal derivative to patients over a duration of at least three months. The effective synthetic retinal derivatives include 9-cis-retinyl esters, 11-cis-retinyl esters, and their derivatives and congeners. Suitable ester substituents for this treatment include carboxylates of C-C monocarboxylic acids and C-C polycarboxylic acids.

Career Highlights

Tadao Maeda is affiliated with the University of Washington, where he continues to contribute to research and development in his field. His work has garnered attention for its potential impact on improving the quality of life for individuals suffering from retinal dysfunction.

Collaborations

Maeda has collaborated with esteemed colleagues such as David A Saperstein and Krzysztof Palczewski. These partnerships have further enhanced the research and development of innovative treatments in ophthalmology.

Conclusion

Tadao Maeda's contributions to the field of retinal health through his patents and collaborations highlight his commitment to advancing medical science. His innovative methods for treating age-related retinal dysfunction represent a significant step forward in ophthalmic research.